Upadacitinib and Phototherapy Effective for Vitiligo
Upadacitinib (Rinvoq, AbbVie) was safe and efficacious out to 76 weeks in patients with nonsegmental vitiligo (NSV), with…
Browsing Tag
U.S. Food and Drug Administration; United States Food and Drug Administration; FDA; Food and Drug Administration (FDA); Food and Drug Administration
1 post